Is There Still a Role for First-Line Single Agent Endocrine Therapy in HR+ and HER2- Advanced Breast Cancer?

by Malorni, Luca, Biganzoli, Laura
Published in Breast Care (Basel) (2017)

Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors

by McCartney, Amelia, Malorni, Luca
Published in Br J Cancer (2020)

Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?

by McCartney, Amelia, Di Leo, Angelo, Malorni, Luca
Published in Oncotarget (2018)

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

by Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Published in BMC Med (2015)

A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer

by Turner, Natalie, Forcato, Mattia, Nuzzo, Simona, Malorni, Luca, Bicciato, Silvio, Di Leo, Angelo
Published in NPJ Breast Cancer (2015)

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

by De Santo, Irene, McCartney, Amelia, Migliaccio, Ilenia, Di Leo, Angelo, Malorni, Luca
Published in Cancers (Basel) (2019)

Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?

by Turner, Natalie, Pestrin, Marta, Galardi, Francesca, De Luca, Francesca, Malorni, Luca, Di Leo, Angelo
Published 2014

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

by Rossi, Lorenzo, McCartney, Amelia, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo
Published in Ther Adv Med Oncol (2018)

What is the real impact of estrogen receptor status on the prognosis and treatment of HER2-positive early breast cancer?

by Brandão, Mariana, Caparica, Rafael, Malorni, Luca, Prat, Aleix, Carey, Lisa A., Piccart-Gebhart, Martine
Published in Clin Cancer Res (2020)

Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response

by Guarducci, Cristina, Bonechi, Martina, Boccalini, Giulia, Benelli, Matteo, Risi, Emanuela, Di Leo, Angelo, Malorni, Luca, Migliaccio, Ilenia
Published in Breast Care (Basel) (2017)

The role of abemaciclib in treatment of advanced breast cancer

by McCartney, Amelia, Moretti, Erica, Sanna, Giuseppina, Pestrin, Marta, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo
Published in Ther Adv Med Oncol (2018)

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer

by Vignoli, Alessia, Risi, Emanuela, McCartney, Amelia, Migliaccio, Ilenia, Moretti, Erica, Malorni, Luca, Luchinat, Claudio, Biganzoli, Laura, Tenori, Leonardo
Published in Int J Mol Sci (2021)

Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients

by Pestrin, Marta, Salvianti, Francesca, Galardi, Francesca, De Luca, Francesca, Turner, Natalie, Malorni, Luca, Pazzagli, Mario, Di Leo, Angelo, Pinzani, Pamela
Published in Mol Oncol (2014)

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer

by Migliaccio, Ilenia, Leo, Angela, Galardi, Francesca, Guarducci, Cristina, Fusco, Giulio Maria, Benelli, Matteo, Di Leo, Angelo, Biganzoli, Laura, Malorni, Luca
Published in Cancers (Basel) (2021)

Development of resistance to targeted therapies transforms the clinically-associated molecular profile subtype of breast tumor xenografts

by Creighton, Chad J., Massarweh, Suleiman, Huang, Shixia, Tsimelzon, Anna, Shou, Jiang, Malorni, Luca, Hilsenbeck, Susan G., Osborne, C. Kent, Schiff, Rachel
Published 2008

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with...

by Malorni, Luca, Piazza, Silvano, Ciani, Yari, Guarducci, Cristina, Bonechi, Martina, Biagioni, Chiara, Hart, Christopher D., Verardo, Roberto, Leo, Angelo Di, Migliaccio, Ilenia
Published in Oncotarget (2016)

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

by Galardi, Francesca, De Luca, Francesca, Romagnoli, Dario, Biagioni, Chiara, Moretti, Erica, Biganzoli, Laura, Di Leo, Angelo, Migliaccio, Ilenia, Malorni, Luca, Benelli, Matteo
Published in Biomolecules (2020)

ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data

by Romagnoli, Dario, Boccalini, Giulia, Bonechi, Martina, Biagioni, Chiara, Fassan, Paola, Bertorelli, Roberto, Sanctis, Veronica De, Leo, Angelo Di, Migliaccio, Ilenia, Malorni, Luca, Benelli, Matteo
Published in BMC Genomics (2018)

Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis

by Barba, Maddalena, Yang, Li, Schünemann, Holger J, Sperati, Francesca, Grioni, Sara, Stranges, Saverio, Westerlind, Kim C, Blandino, Giovanni, Gallucci, Michele, Lauria, Rossella, Malorni, Luca, Muti, Paola
Published 2009

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

by Migliaccio, Ilenia, Wu, Meng-Fen, Gutierrez, Carolina, Malorni, Luca, Mohsin, Syed K., Allred, D. Craig, Hilsenbeck, Susan G., Osborne, C. Kent, Weiss, Heidi, Lee, Adrian V.
Published 2009